Stemetix, Inc.
NEEDHAM, United States · Founded 2016 · $1.6M raised
- Headquarters
- NEEDHAM, Massachusetts
- Employees
- 1–10
- Founded
- 2016
- Business Model
- B2B
- Total Funding
- $1.6M
About
Stemetix, Inc. is a Needham, Massachusetts biotechnology company focused on small-molecule drug development for neurological recovery following stroke and traumatic brain injury. The company discovered novel small molecules that bind to the FGF-2/receptor (FGFR1) complex and enhance FGF-2 signal transduction, promoting neurological recovery after ischemic stroke. Stemetix was founded by Seth Finklestein (CEO) and Ray Soumya, with scientific roots in research at Harvard/Massachusetts General Hospital. The company received HHS SBIR funding including a $1.35M grant in 2018. According to secondary sources, Stemetix is currently inactive (deadpooled).
Summary
Stemetix, Inc. is a Biotech company based in NEEDHAM, United States, founded in 2016. It has raised $1.6M in total.
Funding History
No funding data available yet.
Know something? Help us improve our data.
Similar Companies
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.